A phase three clinical trial that UT Southwestern participated in determined that a three-drug combination improved lung function and reduced symptoms in cystic fibrosis (CF) patients who have a single copy of the most common ...
Nov 1, 2019
0
90
Thousands of genes are involved in the regulation of our day-to-day metabolism and relatively little is understood about their function. One key protein, an ABC Transporter called ABCC5, has recently been predicted to be ...
Jul 24, 2019
0
87
Vitamin D plays a large role in overall health, but it can be challenging to absorb sufficient levels—especially in the colder months. A Baylor College of Medicine expert provides tips on how to maintain your vitamin D ...
Nov 10, 2023
0
25
(Medical Xpress)—An international team of researchers has found that the drug navitoclax can induce apoptosis (self-destruction) in myofibroblasts in mice, reducing the spread of fibrosis in scleroderma. In their paper ...
Yale researchers have found that liver fibrosis—scarring of the liver tissue that occurs in many chronic liver diseases—is associated with reduce cognitive ability and, in certain regions of the brain, reduced brain volume. ...
Jun 26, 2023
0
86
A team of scientists from the UNC School of Medicine and North Carolina State University (NCSU) has developed promising research towards a possible stem cell treatment for several lung conditions, such as idiopathic pulmonary ...
Aug 3, 2017
0
531
A new study has found that a simple, one-off treatment was able to prevent long term side effects of cancer radiotherapies.
May 23, 2022
0
109
The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, has stopped one arm of a three arm multi-center, clinical trial studying treatments for the lung-scarring disease idiopathic ...
Oct 21, 2011
0
0
A Yale-led collaborative study boosts scientific understanding of how the lung disease idiopathic pulmonary fibrosis (IPF) progresses, providing a roadmap for researchers to discover new treatment targets for the disease.
Nov 15, 2019
0
75
While most people recover from COVID-19 within a week or two, up to one-third of survivors experience persistent or new symptoms weeks and months after initial infection.
Jul 20, 2022
0
101
